Literature DB >> 3055180

Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins.

R Labia1, A Morand, K Tiwari, J Sirot, D Sirot, A Petit.   

Abstract

The kinetic constants of three recently identified plasmid-mediated beta-lactamases--SHV-2, CTX-1, and CAZ-1--markedly active against third-generation cephalosporins were analyzed in comparison with three better-characterized beta-lactamases--two plasmid-mediated enzymes, TEM-2 and PIT-2/SHV-1, and R-30, a beta-lactamase from Klebsiella oxytoca that has few similarities to the newer enzymes. All of these enzymes are synthesized constitutively, demonstrate efficient hydrolysis of penicillins, are highly susceptible to the action of clavulanic acid and sulbactam, and have no detectable activity against the cephamycins and imipenem. With the methoxyimino cephalosporins, including those of the third generation, the rates of hydrolysis observed for the SHV-2, CTX-1, and CAZ-1 enzymes are high and show no relation to those observed for the other presently known beta-lactamases. Structure-activity relations suggest that the oxime substituent of these cephalosporins is a major structural factor in the catalytic process observed with the three new beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055180     DOI: 10.1093/clinids/10.4.885

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  17 in total

1.  Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid.

Authors:  D Billot-Klein; L Gutmann; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

2.  Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay.

Authors:  G A Papanicolaou; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 3.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

4.  Mutations altering substrate specificity in OHIO-1, and SHV-1 family beta-lactamase.

Authors:  D M Shlaes; C Currie-McCumber
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

5.  Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France.

Authors:  M J Soilleux; A M Morand; G J Arlet; M R Scavizzi; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

Review 6.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

7.  Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.

Authors:  C Chanal-Claris; D Sirot; L Bret; P Chatron; R Labia; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

8.  Biochemical characteristics of extended broad spectrum beta-lactamases.

Authors:  K Bush; S B Singer
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

Review 9.  Extended-spectrum beta-lactamases.

Authors:  A Philippon; R Labia; G Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

10.  Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model.

Authors:  L B Rice; L L Carias; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.